A Genome-Wide Association Study in Chronic Obstructive Pulmonary Disease (COPD): Identification of Two Major Susceptibility Loci

There is considerable variability in the susceptibility of smokers to develop chronic obstructive pulmonary disease (COPD). The only known genetic risk factor is severe deficiency of α1-antitrypsin, which is present in 1–2% of individuals with COPD. We conducted a genome-wide association study (GWAS) in a homogenous case-control cohort from Bergen, Norway (823 COPD cases and 810 smoking controls) and evaluated the top 100 single nucleotide polymorphisms (SNPs) in the family-based International COPD Genetics Network (ICGN; 1891 Caucasian individuals from 606 pedigrees) study. The polymorphisms that showed replication were further evaluated in 389 subjects from the US National Emphysema Treatment Trial (NETT) and 472 controls from the Normative Aging Study (NAS) and then in a fourth cohort of 949 individuals from 127 extended pedigrees from the Boston Early-Onset COPD population. Logistic regression models with adjustments of covariates were used to analyze the case-control populations. Family-based association analyses were conducted for a diagnosis of COPD and lung function in the family populations. Two SNPs at the α-nicotinic acetylcholine receptor (CHRNA 3/5) locus were identified in the genome-wide association study. They showed unambiguous replication in the ICGN family-based analysis and in the NETT case-control analysis with combined p-values of 1.48×10−10, (rs8034191) and 5.74×10−10 (rs1051730). Furthermore, these SNPs were significantly associated with lung function in both the ICGN and Boston Early-Onset COPD populations. The C allele of the rs8034191 SNP was estimated to have a population attributable risk for COPD of 12.2%. The association of hedgehog interacting protein (HHIP) locus on chromosome 4 was also consistently replicated, but did not reach genome-wide significance levels. Genome-wide significant association of the HHIP locus with lung function was identified in the Framingham Heart study (Wilk et al., companion article in this issue of PLoS Genetics; doi:10.1371/journal.pgen.1000429). The CHRNA 3/5 and the HHIP loci make a significant contribution to the risk of COPD. CHRNA3/5 is the same locus that has been implicated in the risk of lung cancer.

[1]  M. Lebowitz,et al.  Family aggregation of pulmonary function measurements. , 1984, The American review of respiratory disease.

[2]  A. Buist,et al.  Cigarette smoking and health. , 1985, The American review of respiratory disease.

[3]  N. Zamel,et al.  Pulmonary function in identical twins: comparison of nonsmokers and smokers. , 2015, The American review of respiratory disease.

[4]  A. Nagler,et al.  A new MALDI-TOF-based assay for monitoring JAK2 V617F mutation level in patients undergoing allogeneic stem cell transplantation (allo SCT) for classic myeloproliferative disorders (MPD). , 2008, Leukemia research.

[5]  N. Birdsall,et al.  International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. , 1998, Pharmacological reviews.

[6]  P. Muglia,et al.  α-5/α-3 nicotinic receptor subunit alleles increase risk for heavy smoking , 2008, Molecular Psychiatry.

[7]  K. Carlsen,et al.  Asthma in every fifth child in Oslo, Norway: a 10‐year follow up of a birth cohort study * , 2006, Allergy.

[8]  E. Rice-wray.  CIGARETTE SMOKING AND HEALTH. , 1964, American journal of public health and the nation's health.

[9]  Steven Piantadosi,et al.  A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. , 2003, The New England journal of medicine.

[10]  Paolo Vineis,et al.  A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 , 2008, Nature.

[11]  F. Kauffmann.  SERPINE2 and COPD. , 2012, American journal of respiratory and critical care medicine.

[12]  Daniel F. Gudbjartsson,et al.  A variant associated with nicotine dependence, lung cancer and peripheral arterial disease , 2008, Nature.

[13]  M. Lebowitz,et al.  Quantitative relationships between cigarette smoking and ventilatory function. , 1977, The American review of respiratory disease.

[14]  Jacques Fellay,et al.  WGAViewer: software for genomic annotation of whole genome association studies. , 2008, Genome research.

[15]  T. Manolio,et al.  How to Interpret a Genome-wide Association Study Topic Collections , 2022 .

[16]  C. Laurell,et al.  Obstructive lung disease and trypsin inhibitors in alpha-1-antitrypsin deficiency. , 1967, Scandinavian journal of clinical and laboratory investigation.

[17]  D. Mannino,et al.  Cigarette smoking and health. American Thoracic Society. , 1996, American journal of respiratory and critical care medicine.

[18]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[19]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[20]  C. Laurell,et al.  Obstructive Lung Disease and Trypsin Inhibitors in α1-Antitrypsin Deficiency , 1967 .

[21]  B. Cohen.  COMMON FAMILIAL COMPONENT IN LUNG CANCER AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE , 1978, The Lancet.

[22]  N J Wareham,et al.  Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction. , 2001, American journal of respiratory and critical care medicine.

[23]  Christoph Lange,et al.  PBAT: tools for family-based association studies. , 2004, American journal of human genetics.

[24]  S. Hawgood.  Surfactant Protein B: Structure and Function , 2004, Neonatology.

[25]  C. Kirkpatrick,et al.  Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans. , 1998, Pharmacology & therapeutics.

[26]  G. Mills,et al.  Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1 , 2008, Nature Genetics.

[27]  A. Aromaa,et al.  Letter: Mortality and anaemia. , 1974, Lancet.

[28]  D. Strayer,et al.  DNA binding proteins that amplify surfactant protein B gene expression: isolation and characterization. , 1995, Biochemical and biophysical research communications.

[29]  Nicholas G Martin,et al.  Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. , 2007, Human molecular genetics.

[30]  Alan D. Lopez,et al.  Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.

[31]  B Rosner,et al.  Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. , 1998, American journal of respiratory and critical care medicine.

[32]  Albert Damon,et al.  The Normative Aging Study: An Interdisciplinary and Longitudinal Study of Health and Aging , 1972 .

[33]  S. Redline,et al.  Genotypic and phenotypic similarities in pulmonary function among family members of adult monozygotic and dizygotic twins. , 1989, American journal of epidemiology.

[34]  Edwin K Silverman,et al.  The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations. , 2006, American journal of respiratory and critical care medicine.

[35]  F. Speizer,et al.  Familial factors related to lung function in children aged 6-10 years. Results from the PAARC epidemiologic study. , 1989, American journal of epidemiology.